News & Analysis on Clinical Trial Services & Contract Research And Development
Bruker AXS, a subsidiary of the Bruker BioSciences Corporation, has announced an agreement to purchase Roentec, an x-ray microanalysis instrumentation company that signals Bruker's intention to reinforce its standing within this sector.
Actavis's $810 million (€677 million) cash acquisition of Alpharma's US and international generic drugs division is part of the firm's strategy to become one of the global leaders in the sector.
The Food and Drug Administration has approved Flexbumin, the first human albumin preparation to be packaged in a flexible container, reducing the risk of breakage while being more compatible with hospital inventory storage systems.
Dutch pharmaceuticals and chemicals giant Akzo Nobel reported third-quarter sales of €3,29 billion, a slight decrease from the previous quarter but up 5.4 per cent from the comparable period in 2004, thanks to growth in all its units, particularly in...